Toggle navigation
Home
Search
Services
Blog
Contact
About
Receptor Kinase Gene Therapy for Neointimal Hyperplasia
Freedman, Neil J.
Duke University, Durham, NC, United States
Search 45 grants from Neil Freedman
Search grants from Duke University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Strategies to Improve Outcomes for triple negative Breast Cancer Patients involv
Recognition and Catalysis of Phosphotyrosyl Proteins
Gastroparesis Clinical Research Consortium-University of Michigan Clinical Center
Intermediate Filament Cell Surface Interactions
Urodeoxycholic Acid Treatment of Primary Biliary Cirrhosis
Recently added grants:
Data Management and Analysis Core
Human dendritic cell function in cytomegalovirus infection
T cell immunity to cytomegalovirus in tissues and circulation
Multiscale analysis of tissue macrophage response to CMV
Synthetic rescue of antigen-driven T cells and alloimmunity
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29HL057432-02
Application #
6047892
Study Section
Surgery and Bioengineering Study Section (SB)
Project Start
1997-09-01
Project End
2001-07-31
Budget Start
1998-08-01
Budget End
1999-07-31
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Institution
Name
Duke University
Department
Type
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Related projects
NIH 1998
R29 HL
Receptor Kinase Gene Therapy for Neointimal Hyperplasia
Freedman, Neil J. / Duke University
NIH 1997
R29 HL
Receptor Kinase Gene Therapy for Neointimal Hyperplasia
Freedman, Neil J. / Duke University
Comments
Be the first to comment on Neil Freedman's grant